Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.93
-$1.99-10.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.61% | 15.80% | 2.59% | 5.41% | 14.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.61% | 15.80% | 2.59% | 5.41% | 14.70% |
| Cost of Revenue | 15.35% | 11.68% | 1.41% | 4.19% | 12.84% |
| Gross Profit | 22.39% | 18.50% | 3.42% | 6.25% | 15.94% |
| SG&A Expenses | 11.27% | 7.73% | 8.56% | 11.53% | 15.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.79% | 10.17% | 4.85% | 7.73% | 13.80% |
| Operating Income | 44.44% | 39.84% | -4.94% | -2.33% | 18.70% |
| Income Before Tax | 48.35% | 43.64% | -56.71% | -55.52% | 21.23% |
| Income Tax Expenses | 61.45% | 56.32% | 14.51% | 17.65% | 78.36% |
| Earnings from Continuing Operations | 44.29% | 39.70% | -84.06% | -83.62% | 10.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.29% | 39.70% | -84.06% | -83.62% | 10.27% |
| EBIT | 44.44% | 39.84% | -4.94% | -2.33% | 18.70% |
| EBITDA | 40.43% | 35.97% | -0.12% | 2.62% | 15.36% |
| EPS Basic | 43.29% | 38.70% | -84.17% | -83.75% | 9.61% |
| Normalized Basic EPS | 47.16% | 42.52% | -12.67% | -10.33% | 20.53% |
| EPS Diluted | 42.73% | 38.31% | -84.41% | -84.00% | 10.08% |
| Normalized Diluted EPS | 47.03% | 42.37% | -12.76% | -10.53% | 20.37% |
| Average Basic Shares Outstanding | 0.75% | 0.75% | 0.79% | 0.79% | 0.54% |
| Average Diluted Shares Outstanding | 0.83% | 0.83% | 0.87% | 0.87% | 0.70% |
| Dividend Per Share | 4.04% | 0.54% | -0.55% | 2.16% | 1.30% |
| Payout Ratio | -0.25% | -0.25% | 3.96% | 3.96% | -0.44% |
